Search





Search





Nautilus Biotechnology Inc

NAUT

Add to Watchlist

0.955USD

-0.011-1.14%

Close 09-21 16:00（ET）

121.50MMarket Cap

LossP/E TTM

Nautilus Biotechnology Inc

0.955

-0.011-1.14%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

NAUT Cash Flow Statement

You can access the annual and quarterly cash flow statements of Nautilus Biotechnology Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-2.82%-13.73M

6.01%-13.10M

13.52%-12.38M

15.85%-11.03M

13.63%-13.35M

14.32%-13.94M

-2.94%-14.31M

-11.71%-13.11M

-14.08%-15.46M

-29.88%-16.27M

-33.95%-13.90M

-22.72%-11.74M

-0.15%-13.55M

-1.53%-12.52M

1.35%-10.38M

32.53%-9.56M

-63.16%-13.53M

-97.27%-12.34M

---10.52M

-320.56%-14.18M

-153.04%-8.29M

-138.57%-6.25M

---3.37M

---3.28M

---2.62M

Net income from continuing operations

3.75%-14.47M

11.53%-14.70M

21.67%-13.78M

17.46%-13.57M

16.53%-15.03M

11.30%-16.61M

-3.35%-17.59M

-3.58%-16.45M

-13.93%-18.01M

-25.16%-18.73M

-26.96%-17.02M

-12.91%-15.88M

-7.62%-15.81M

5.06%-14.96M

19.65%-13.41M

3.04%-14.06M

-37.11%-14.69M

-87.45%-15.76M

---16.69M

-264.61%-14.50M

-219.31%-10.71M

-186.61%-8.41M

---3.98M

---3.35M

---2.93M

Operating gains losses

-40.48%272.00K

-28.17%334.00K

-6.25%405.00K

-17.28%426.00K

-10.74%457.00K

-9.88%465.00K

-22.16%432.00K

10.04%515.00K

16.10%512.00K

34.03%516.00K

60.40%555.00K

51.46%468.00K

56.94%441.00K

37.01%385.00K

31.56%346.00K

11.55%309.00K

6.04%281.00K

31.31%281.00K

--263.00K

46.56%277.00K

56.80%265.00K

35.44%214.00K

--189.00K

--169.00K

--158.00K

Other non-cash items

38.94%1.02M

73.51%1.07M

-16.28%1.05M

137.17%887.00K

92.43%737.00K

91.05%619.00K

201.20%1.25M

-3.36%374.00K

38.27%383.00K

176.92%324.00K

1564.00%416.00K

8.10%387.00K

-26.13%277.00K

-78.77%117.00K

-95.83%25.00K

-17.51%358.00K

-15.73%375.00K

4.36%551.00K

--599.00K

-12.32%434.00K

6.71%445.00K

5.81%528.00K

--495.00K

--417.00K

--499.00K

Change in working capital

-40.25%-1.71M

-103.65%-1.17M

5.53%-1.52M

63.65%-269.00K

24.74%-1.22M

61.34%-576.00K

-74.78%-1.61M

-513.41%-740.00K

-4.11%-1.62M

-61.78%-1.49M

-434.88%-920.00K

-81.37%179.00K

24.53%-1.56M

-289.51%-921.00K

-106.51%-172.00K

136.51%961.00K

-1792.66%-2.06M

523.08%486.00K

--2.64M

-1835.29%-2.63M

80.15%-109.00K

121.49%78.00K

---136.00K

---549.00K

---363.00K

-Change in prepaid expenses

-8442.86%-598.00K

-312.57%-355.00K

-42.92%395.00K

-124.44%-11.00K

-102.94%-7.00K

154.05%167.00K

1114.04%692.00K

149.45%45.00K

186.86%238.00K

39.77%-309.00K

-88.97%57.00K

-112.26%-91.00K

74.08%-274.00K

-192.60%-513.00K

-53.42%517.00K

121.03%742.00K

-1861.67%-1.06M

241.69%554.00K

--1.11M

-70480.00%-3.53M

125.21%60.00K

-421.33%-391.00K

---5.00K

---238.00K

---75.00K

-Change in other current liabilities

8.72%-1.06M

-0.79%-1.15M

-11.39%-1.21M

-14.01%-1.18M

-13.64%-1.16M

-12.91%-1.14M

-8.04%-1.09M

-25.45%-1.03M

-20.02%-1.02M

-91.44%-1.01M

-91.27%-1.01M

-85.39%-825.00K

-93.84%-849.00K

-3022.22%-526.00K

-143.09%-527.00K

-14.69%-445.00K

25.64%-438.00K

107.32%18.00K

--1.22M

-2.37%-388.00K

-58.76%-589.00K

43.58%-246.00K

---379.00K

---371.00K

---436.00K

Cash from non-recurring investing activities

Cash from operating activities

-2.82%-13.73M

6.01%-13.10M

13.52%-12.38M

15.85%-11.03M

13.63%-13.35M

14.32%-13.94M

-2.94%-14.31M

-11.71%-13.11M

-14.08%-15.46M

-29.88%-16.27M

-33.95%-13.90M

-22.72%-11.74M

-0.15%-13.55M

-1.53%-12.52M

1.35%-10.38M

32.53%-9.56M

-63.16%-13.53M

-97.27%-12.34M

---10.52M

-320.56%-14.18M

-153.04%-8.29M

-138.57%-6.25M

---3.37M

---3.28M

---2.62M

Investing cash flow

Net cash from continuing investing activities

14.65%454.00K

132.88%510.00K

-3.94%244.00K

-41.04%418.00K

-22.66%396.00K

-66.15%219.00K

100.51%254.00K

-98.60%709.00K

10.58%512.00K

-6.50%647.00K

-21695.20%-49.45M

5168.95%50.74M

-28.88%463.00K

43.87%692.00K

-76.77%229.00K

256.67%963.00K

-35.74%651.00K

--481.00K

--986.00K

-99.60%270.00K

185.35%1.01M

----

--68.00M

--355.00K

----

Capital expenditures

14.65%454.00K

132.88%510.00K

-3.94%244.00K

-41.04%418.00K

-22.66%396.00K

-66.15%219.00K

--254.00K

-98.60%709.00K

10.58%512.00K

-6.50%647.00K

----

5168.95%50.74M

-28.88%463.00K

43.87%692.00K

-76.77%229.00K

256.67%963.00K

-35.74%651.00K

--481.00K

--986.00K

-99.60%270.00K

185.35%1.01M

----

--68.00M

--355.00K

----

Net cash flow from disposal of fixed assets

14.65%454.00K

132.88%510.00K

-3.94%244.00K

-41.04%418.00K

-22.66%396.00K

-66.15%219.00K

100.51%254.00K

-98.60%709.00K

10.58%512.00K

-6.50%647.00K

-21695.20%-49.45M

5168.95%50.74M

-28.88%463.00K

43.87%692.00K

-76.77%229.00K

256.67%963.00K

-35.74%651.00K

--481.00K

--986.00K

-99.60%270.00K

185.35%1.01M

----

--68.00M

--355.00K

----

Net cash flow from investment products

-16.10%12.48M

-25.28%14.74M

-97.30%1.03M

112.81%870.00K

0.43%14.87M

-14.22%19.73M

142.12%38.12M

-110.65%-6.79M

926.23%14.81M

279.65%23.00M

-41.81%-90.51M

681.19%63.81M

-105.02%-1.79M

-181.74%-12.80M

-1005.33%-63.83M

86.88%-10.98M

142.76%35.73M

-33.40%15.66M

--7.05M

-261.86%-83.71M

-84.78%-83.55M

198.22%23.52M

--51.72M

---45.22M

--7.89M

Net cash flow from other investing activities

--0.00

----

100.00%0.00

----

---760.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-16.94%12.02M

-27.05%14.23M

-97.88%787.00K

106.02%452.00K

1.26%14.47M

-12.71%19.51M

190.37%37.11M

-157.38%-7.50M

733.88%14.29M

265.64%22.35M

35.90%-41.06M

209.48%13.07M

-106.43%-2.25M

-188.89%-13.49M

-1156.32%-64.06M

85.78%-11.94M

141.48%35.08M

-35.45%15.18M

--6.06M

-415.59%-83.98M

-85.56%-84.57M

198.22%23.52M

---16.29M

---45.57M

--7.89M

Financing cash flow

Cash flow from continuous financing activities

156.84%244.00K

6038.89%1.10M

-77.05%101.00K

-100.00%0.00

-70.22%95.00K

-92.65%18.00K

73.91%440.00K

775.00%140.00K

225.51%319.00K

24400.00%245.00K

87.41%253.00K

-81.40%16.00K

-47.03%98.00K

-99.36%1.00K

114.29%135.00K

681.82%86.00K

-99.94%185.00K

107.54%156.00K

--63.00K

-60.71%11.00K

334.27%329.44M

---2.07M

--28.00K

--75.86M

--0.00

Net cash flow from common stock issuance/repurchase

63.22%142.00K

----

-70.64%69.00K

--0.00

-69.90%87.00K

----

36.63%235.00K

--0.00

214.13%289.00K

----

117.72%172.00K

--0.00

-39.87%92.00K

----

--79.00K

--0.00

--153.00K

----

Proceeds from stock option exercised by employees

1175.00%102.00K

6038.89%1.10M

-84.39%32.00K

-100.00%0.00

-73.33%8.00K

-92.65%18.00K

153.09%205.00K

775.00%140.00K

400.00%30.00K

24400.00%245.00K

44.64%81.00K

-81.40%16.00K

-81.25%6.00K

-99.36%1.00K

-11.11%56.00K

48.28%86.00K

-30.43%32.00K

--156.00K

--63.00K

107.14%58.00K

1050.00%46.00K

----

--28.00K

--4.00K

----

Net cash flow from other financing activities

--142.00K

----

--0.00

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---47.00K

334.23%329.40M

---2.07M

--0.00

--75.86M

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

156.84%244.00K

6038.89%1.10M

-77.05%101.00K

-100.00%0.00

-70.22%95.00K

-92.65%18.00K

73.91%440.00K

775.00%140.00K

225.51%319.00K

24400.00%245.00K

87.41%253.00K

-81.40%16.00K

-47.03%98.00K

-99.36%1.00K

114.29%135.00K

681.82%86.00K

-99.94%185.00K

107.54%156.00K

--63.00K

-60.71%11.00K

334.27%329.44M

---2.07M

--28.00K

--75.86M

--0.00

Net cash flow

Beginning cash balance

-54.36%15.63M

-53.26%13.39M

359.75%24.88M

36.98%35.46M

28.09%34.24M

40.44%28.65M

-92.80%5.41M

-64.90%25.89M

-70.12%26.73M

-82.34%20.40M

-60.42%75.11M

-65.08%73.75M

-52.78%89.46M

-38.07%115.48M

-0.57%189.77M

-26.92%211.20M

261.47%189.46M

400.98%186.46M

--190.85M

779.19%289.00M

794.45%52.41M

6155.29%37.22M

--32.87M

--5.86M

--595.00K

Current period cash flow changes

-219.77%-1.46M

-59.98%2.24M

-149.43%-11.49M

48.32%-10.58M

244.43%1.22M

-11.69%5.59M

142.48%23.24M

-1613.38%-20.48M

94.63%-844.00K

124.34%6.33M

26.37%-54.71M

106.32%1.35M

-172.27%-15.71M

-966.40%-26.02M

-1591.64%-74.30M

78.17%-21.42M

-90.81%21.73M

-80.24%3.00M

---4.39M

-399.95%-98.15M

775.88%236.58M

188.62%15.20M

---19.63M

--27.01M

--5.26M

Ending cash balance

-60.04%14.17M

-54.36%15.63M

-53.26%13.39M

359.75%24.88M

36.98%35.46M

28.09%34.24M

40.44%28.65M

-92.80%5.41M

-64.90%25.89M

-70.12%26.73M

-82.34%20.40M

-60.42%75.11M

-65.08%73.75M

-52.78%89.46M

-38.07%115.48M

-0.57%189.77M

-26.92%211.20M

261.47%189.46M

--186.46M

1341.49%190.85M

779.19%289.00M

794.45%52.41M

--13.24M

--32.87M

--5.86M

Free cash flow

-3.16%-14.18M

3.86%-13.61M

13.35%-12.62M

17.15%-11.45M

13.92%-13.75M

16.30%-14.16M

-4.77%-14.56M

77.88%-13.82M

-13.97%-15.97M

-27.97%-16.91M

-31.06%-13.90M

-493.45%-62.48M

1.18%-14.01M

-3.12%-13.22M

7.81%-10.61M

27.13%-10.53M

-52.39%-14.18M

-104.96%-12.82M

---11.51M

79.76%-14.45M

-156.19%-9.30M

-138.57%-6.25M

---71.38M

---3.63M

---2.62M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Nautilus Biotechnology Inc Generate?



Nautilus Biotechnology Inc generated -50.70M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Nautilus Biotechnology Inc's Operating Cash Flow Change Year Over Year?



Nautilus Biotechnology Inc's operating cash flow increased by 14.29% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Nautilus Biotechnology Inc Spend on Capital Expenditures?



Nautilus Biotechnology Inc spent 1.28M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Nautilus Biotechnology Inc's Financing Cash Flow Changed?



Nautilus Biotechnology Inc used 214.00K in financing activities in the latest quarter.

What is free cash flow and why does it matter for NAUT?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Nautilus Biotechnology Inc’s free cash flow in the latest quarter?



Free cash flow was -51.97M reflecting a 15.17% change from the previous year.